Noticias de ADPT_US
Noticias del mercado
Últimas noticias sobre ADPT_US — 172 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 11,881 shares of the stock in a transaction dated Friday, October 2nd. The stock was sold at an average price of $28.13, for a total value of $334,212.53. Following the transaction, the chief operating officer directly owned 377,802 shares in the company, valued at approximately $10,627,570.26. The trade was a 3.05% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Francis Lo sold 26,792 shares of the firm
Adaptive Biotechnologies Corporation (ADPT) is down 3.5% today. Here is some analysis on what might
Adaptive Biotechnologies Corporation (ADPT) is down 3.5% today. Here is some analysis on what might
Página 4 de 9